{"id":54175,"date":"2025-10-07T14:00:47","date_gmt":"2025-10-07T18:00:47","guid":{"rendered":"https:\/\/stockmarketwatch.com\/stock-market-news\/the-trump-market-where-chaos-is-the-new-calm-and-stocks-still-soar\/54175\/"},"modified":"2025-10-07T14:00:47","modified_gmt":"2025-10-07T18:00:47","slug":"the-trump-market-where-chaos-is-the-new-calm-and-stocks-still-soar","status":"publish","type":"post","link":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/the-trump-market-where-chaos-is-the-new-calm-and-stocks-still-soar\/54175\/","title":{"rendered":"The Trump Market: Where Chaos is the New Calm (and Stocks Still Soar)"},"content":{"rendered":"

Ah, October 2025. The leaves are turning, the air is crisp, and the United States government is, once again, partially shut down. One might expect Wall Street to be in a state of existential dread, perhaps clutching pearls and predicting economic Armageddon. Yet, in a testament to either profound resilience or an advanced stage of policy-induced delirium, the major indices are largely shrugging off the federal paralysis, with some even hitting fresh, dizzying highs. It seems the market, much like a seasoned reality TV viewer, has simply learned to embrace the drama, especially when President Donald Trump<\/a> is the executive producer.<\/p>\n

The Shutdown That Wasn’t (for Your Portfolio)<\/h2>\n

As the federal government slogs through its second week of a partial shutdown, a situation that would typically send shivers down the spines of investors, the S&P 500<\/a> has been busy defying gravity. On October 7, 2025, the index closed at an impressive 6,740.28 points, marking an extraordinary eighth consecutive day of gains and setting a new all-time high. Not to be entirely left out, the Nasdaq Composite<\/a> also climbed a respectable 0.71% to 22941.667 points. The venerable Dow Jones Industrial Average<\/a>, ever the traditionalist, did manage to dip 0.14% to 46694.97 points, thereby halting its own six-session winning streak and offering a fleeting moment of market normalcy.<\/p>\n

Analysts, those brave souls tasked with rationalizing the seemingly irrational, are largely unfazed. UBS, for instance, sagely advised investors to “look past shutdown fears and focus on other market drivers, such as the mix of continued Fed rate cuts, strong corporate earnings, and robust AI capex and monetization.” In other words, “Don’t mind the man behind the curtain, the robots are still making money.” Indeed, the consensus seems to be that the economic impact of a brief shutdown is “limited,” with most economic activity merely “delayed” rather than lost. This, of course, offers little comfort to the hundreds of thousands of federal workers currently wondering if their next paycheck will arrive, but for the algorithms driving Wall Street, it’s apparently just background noise. The only real concern, some suggest, is the “data blackout” \u2013 the temporary cessation of government economic reports \u2013 leaving investors to fly blind, presumably guided by the President’s latest Truth Social missives.<\/p>\n

The Tariff Tango: Trucks Today, Drugs Yesterday<\/h2>\n

If there’s one thing President Trump<\/a> loves more than a good rally, it’s a good tariff. And this week, it was the turn of foreign heavy-duty trucks to feel the heat. On October 6th and 7th, the President took to his preferred communication channel, Truth Social, to announce a new 25% tariff on all imported medium- and heavy-duty trucks, set to commence on November 1, 2025. This, of course, came after a *previous* announcement of similar tariffs in late September that, much like a poorly scheduled flight, didn’t quite take off as expected. The stated goal: to protect American manufacturers from “unfair outside competition” and revive domestic production.<\/p>\n

The industry’s reaction was predictably less enthusiastic. Automakers, ever the pragmatists, warned that these new duties might actually *raise* production costs and *reduce* competitiveness. A spokesperson for Stellantis, for example, reportedly urged the White House to reconsider, labeling the tariffs “counterproductive to North American manufacturing integration.” One can almost hear the collective sigh from the boardrooms. While no immediate, specific stock movements for major truck manufacturers like GM<\/a> or F<\/a> were explicitly tied to this announcement in the immediate aftermath, the market’s general “muted” reaction to such trade pronouncements has become a hallmark of the Trump era.<\/p>\n

Yet, the market’s memory is short, and its appetite for a good deal is insatiable. Just a week prior, a different tariff drama played out, this time involving the pharmaceutical industry. President Trump had, with characteristic flourish, threatened a colossal 100% tariff on branded pharmaceutical imports. The industry, naturally, braced for impact. But then, a pivot! A “multi-pronged deal” was struck with pharmaceutical behemoth Pfizer<\/a>. In exchange for voluntarily agreeing to cut U.S. drug prices (and participate in a new government-backed platform, TrumpRx.gov), Pfizer was granted a coveted three-year exemption from those very same pharmaceutical-specific tariffs.<\/p>\n

The market, ever the optimist when tariffs are *removed* rather than imposed, reacted with unbridled enthusiasm. Pfizer stock surged almost 7% on Tuesday, October 1, 2025, closing up 6.69% at $25.45. This wasn’t just a win for Pfizer; it was a shot in the arm for the entire sector. BMO Capital Markets analyst Evan Seigerman hailed the deal as “positive for both Pfizer and the broader pharmaceutical sector,” noting it “adds certainty and shifts POTUS policies potentially away from Pharma tariffs.” Other major players quickly followed suit: Eli Lilly<\/a> gained 5%, AbbVie<\/a> and AstraZeneca<\/a> climbed over 3%, and Johnson & Johnson<\/a> and Bristol Myers Squibb<\/a> each saw increases of more than 2%. The takeaway? Threaten tariffs, then make a deal to remove them, and watch the market cheer. It’s a strategy that keeps everyone on their toes, and apparently, keeps the bulls running.<\/p>\n

Healthcare’s Rollercoaster: The ACA Conundrum<\/h2>\n

The Affordable Care Act (ACA<\/a>), or Obamacare, has long been a political football, often kicked around with promises of repeal and replacement. Yet, in the ever-evolving Trumpian landscape, even this policy has found a new role as a market mover. Amidst the ongoing government shutdown, largely stalled over Democrats’ insistence on extending expiring ACA subsidies, President Trump offered a glimmer of hope. His comments hinting at a willingness to “negotiate” with Democrats on healthcare, despite previously labeling their policies “failed,” were enough to send healthcare stocks into a celebratory frenzy.<\/p>\n

The market, ever alert to any whisper of stability or compromise, interpreted this as a positive sign. Oscar Health<\/a>, a company heavily exposed to the ACA marketplace, saw its stock surge a remarkable 8% to $20.84 on October 3, 2025. This ripple effect extended across the S&P 500<\/a> Health Care sector, with major insurers experiencing significant gains: Humana<\/a> rose 9.1%, Cigna<\/a> 5.5%, Elevance<\/a> 4.7%, Centene<\/a> 4.5%, Molina<\/a> 3.6%, and UnitedHealth Group<\/a> 2.7%. The iShares U.S. Healthcare ETF<\/a> (IYH<\/a>), which tracks the sector, is up 5.4% year-to-date, though sentiment around it had cooled slightly to “neutral” by October 7th. The irony, of course, is that a policy once targeted for demolition can, with a few well-timed remarks, become a catalyst for market gains. It’s a reminder that in the Trump era, policy isn’t just about governance; it’s a performance art, with market reactions serving as the applause meter.<\/p>\n

The New Normal: Embracing the Unpredictable<\/h2>\n

In conclusion, the stock market under President Trump continues to operate in its own unique dimension, where traditional economic indicators often take a backseat to presidential pronouncements. A government shutdown, once a harbinger of doom, is now merely a backdrop against which the S&P 500<\/a> can achieve new record highs. Tariffs, whether threatened or implemented, are less about consistent trade policy and more about a high-stakes game of chicken that, when resolved (or paused), can send specific sectors soaring.<\/p>\n

The market has seemingly developed an extraordinary ability to discount, or perhaps even thrive on, the constant stream of policy flip-flops and Twitter (or rather, Truth Social) diplomacy. It’s a world where a 25% tariff on trucks is announced, a 100% tariff on drugs is threatened then rescinded for a deal, and a willingness to discuss healthcare subsidies (which were once anathema) can inject billions into health insurer valuations. Investors, it seems, have learned to embrace the ride, understanding that volatility and contradiction are not bugs, but features of this particular market landscape. The only constant, it appears, is the relentless pursuit of profit, even if it means navigating a policy environment that shifts faster than a day trader’s sentiment. And for now, the market keeps finding ways to climb, leaving us all to wonder what absurd, yet profitable, twist will come next.<\/p>\n

DISCLAIMER: <\/b> We read Trump’s posts so you don’t have to. This is comedy meets market data, not financial advice. Not political advice either – we just like charts and chaos.<\/i><\/p>\n","protected":false},"excerpt":{"rendered":"

Ah, October 2025. The leaves are turning, the air is crisp, and the United States government is, once again, partially […]<\/p>\n","protected":false},"author":8,"featured_media":50312,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"rank_math_schema_Article":[],"rank_math_focus_keyword":[],"rank_math_description":[],"financial_data_references":[],"stock_symbols_mentioned":[],"footnotes":""},"categories":[4331],"tags":[],"class_list":["post-54175","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-trump-stock-market"],"_links":{"self":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts\/54175","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/comments?post=54175"}],"version-history":[{"count":0,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts\/54175\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/media\/50312"}],"wp:attachment":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/media?parent=54175"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/categories?post=54175"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/tags?post=54175"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}